Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 4
2009 9
2010 4
2011 7
2012 2
2013 2
2014 1
2015 3
2017 1
2018 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
In vivo effects of a GPR30 antagonist.
Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, Bologa CG, Leitao A, Brailoiu E, Deliu E, Dun NJ, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, Prossnitz ER. Dennis MK, et al. Nat Chem Biol. 2009 Jun;5(6):421-7. doi: 10.1038/nchembio.168. Nat Chem Biol. 2009. PMID: 19430488 Free PMC article.
Emerging roles of GPER in diabetes and atherosclerosis.
Barton M, Prossnitz ER. Barton M, et al. Trends Endocrinol Metab. 2015 Apr;26(4):185-92. doi: 10.1016/j.tem.2015.02.003. Epub 2015 Mar 9. Trends Endocrinol Metab. 2015. PMID: 25767029 Free PMC article. Review.
Estrogen-independent activation of estrogen receptors.
Barton M, Meyer MR, Prossnitz ER. Barton M, et al. Hypertension. 2011 Jun;57(6):1056-7. doi: 10.1161/HYPERTENSIONAHA.111.173427. Epub 2011 May 2. Hypertension. 2011. PMID: 21536981 Free PMC article. No abstract available.
33 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page